Preprints.org

A Comparison of Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors in Reducing the Incidence of Tuberculosis and Mortality in Patients with Diabetes

By Chun-Hsiang Hsu, Renin Chang, Chiu-Fan Chen, Min-Hsi Lin

Preprint: cohort study in peopleInterventions

The paper

Chun-Hsiang Hsu, Renin Chang, Chiu-Fan Chen, Min-Hsi Lin

Preprints.org, 10 Sep 2026, Preprint, not peer-reviewed

doi.org/10.20944/preprints202609.0818.v1

Drug Design, Development and Therapy5 Oct 2026
GLP-1 agonists linked to lower dementia risk after COVID-19
Diabetes & Vascular Disease Research4 Oct 2026
SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes, Obesity & Metabolism8 Oct 2026
Diabetes drug class linked to slightly less frailty progression
Clinical Journal of the American Society of Nephrology4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes